Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
2D and 3D QSAR Analysis of some novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives
Author(s): Mayura Kale, Rajesh Nawale, Gajanan Sonawane and Ratnamala SurvaseQSAR model development was carried out for of 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives that had been evaluated for antiprotozoal activity activity. The physicochemical parameters were calculated using VLIFE MDS 4.5 software. Stepwise multiple linear regression analysis was applied to derive QSAR models, which were further evaluated for statistical significance and predictive power by internal and external validation. The best quantitative structure activity relationship model was selected having a correlation coefficient (r2) of 0.9740, cross-validated correlation coefficient (q2) of 0.9588 and, r2 pred of 0.7691. The predictive ability of the selected model was also confirmed by leave one-out cross-validation. The QSAR model indicates that the descriptors (chiV1,chi3Cluster, XAHydrophobicArea) highly influence antiprotozoal activity. The information derived from the present study may be useful in the design of more potent substituted 2-{[2-(1H-imidazol-1- yl)ethyl]sulfanyl}-1H-benzimidazole derivatives.
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 15261
Der Pharma Chemica received 15261 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
